ESKETAMINE THERAPY

ADMINISTERED VIA NASAL SPRAY AND IS EFFECTIVE WITHIN HOURS

Esketamine was approved by the FDA in 2019  to treat depression that has not responded to other therapies. 

 

Unlike oral antidepressants, which often take four to six weeks to take effect, esketamine is administered via nasal spray and is effective within hours. 

 

It is estimated that 5 million people in the United States have a depressive disorder that hasn’t resolved with current treatments.  Esketamine may help those with treatment-resistant depression experience much-needed relief.

CONTACT US

Please call: 1-334-270-5502 or fill out the following form.

Address: 500 Shae Park Montgomery, AL 36117, USA

© 2020 by River Region Psychiatric Services, LLC.